Literature DB >> 2658591

Glutaric aciduria type II: review of the phenotype and report of an unusual glomerulopathy.

G N Wilson1, J P de Chadarévian, P Kaplan, J P Loehr, F E Frerman, S I Goodman.   

Abstract

A male infant with glutaric aciduria II secondary to electron transfer flavoprotein: ubiquinone oxidoreductase deficiency is compared to previously reported cases of glutaric aciduria II. A common pattern of anomalies in patients with malformations (8/16) includes macrocephaly, large anterior fontanelle, high forehead, flat nasal bridge, telecanthus, and malformed ears. Abnormalities such as hypotonia, cerebral gliosis, heterotopias, hepatomegaly, hepatic periportal necrosis, polycystic kidneys, and genital defects in glutaric aciduria II are reminiscent of those in Zellweger syndrome, whereas elevations of glutaric, ethylmalonic, adipic, and isovaleric acids are quite distinctive. A unique ultrastructural alteration of the glomerular basement membrane was observed in the proposita. This manifestation may represent an early stage in renal cyst formation and provide a diagnostic criterion for glutaric aciduria II when enzyme studies are unavailable.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2658591     DOI: 10.1002/ajmg.1320320326

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  A new variant of glutaric aciduria type II: deficiency of beta-subunit of electron transfer flavoprotein.

Authors:  S Yamaguchi; T Orii; K Maeda; M Oshima; T Hashimoto
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 2.  Fatty acid oxidation disorders.

Authors:  J Lawrence Merritt; Marie Norris; Shibani Kanungo
Journal:  Ann Transl Med       Date:  2018-12

Review 3.  Metabolic disorders of embryogenesis.

Authors:  G K Brown
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

4.  Cardiomyopathy in multiple Acyl-CoA dehydrogenase deficiency: a clinico-pathological correlation and review of literature.

Authors:  Mohit Singla; Grace Guzman; Andrew J Griffin; Saroja Bharati
Journal:  Pediatr Cardiol       Date:  2007-10-03       Impact factor: 1.655

5.  Cystic renal dysplasia as a leading sign of inherited metabolic disease.

Authors:  Felix Distelmaier; Markus Vogel; Ute Spiekerkötter; Klaus Gempel; Dirk Klee; Stefan Braunstein; Heinz-Peter Groneck; Ertan Mayatepek; Udo Wendel; Bernd Schwahn
Journal:  Pediatr Nephrol       Date:  2007-07-19       Impact factor: 3.714

Review 6.  The pathobiology of polycystic kidney disease from a metabolic viewpoint.

Authors:  Luis Fernando Menezes; Gregory G Germino
Journal:  Nat Rev Nephrol       Date:  2019-09-05       Impact factor: 28.314

7.  A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed.

Authors:  Cheng-Chao Lin; Mahiro Kurashige; Yi Liu; Takeshi Terabayashi; Yu Ishimoto; Tanchun Wang; Vineet Choudhary; Ryan Hobbs; Li-Ka Liu; Ping-Hsien Lee; Patricia Outeda; Fang Zhou; Nicholas P Restifo; Terry Watnick; Haruna Kawano; Shigeo Horie; William Prinz; Hong Xu; Luis F Menezes; Gregory G Germino
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

8.  Infantile onset carnitine palmitoyltransferase 2 deficiency: Cortical polymicrogyria, schizencephaly, and gray matter heterotopias in an adolescent with normal development.

Authors:  Ivan Shelihan; Elsa Rossignol; Jean-Claude Décarie; Jean-Paul Bonnefont; Michèle Brivet; Catherine Brunel-Guitton; Grant A Mitchell
Journal:  JIMD Rep       Date:  2021-09-29

9.  Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease.

Authors:  Luis F Menezes; Cheng-Chao Lin; Fang Zhou; Gregory G Germino
Journal:  EBioMedicine       Date:  2016-01-26       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.